Crude model | Model 1 | Model 2 | Model 3 | |
---|---|---|---|---|
Total participants | ||||
Intermittent use vs. no use | 1.05 (0.85,1.30), 0.663 | 0.95 (0.77,1.18), 0.666 | 0.85 (0.79,1.22), 0.851 | 0.99 (0.79,1.24), 0.946 |
Persistent use vs. no use | 1.84 (1.42,2.39), < 0.001 | 1.63 (1.26,2.12), < 0.001 | 1.73 (1.33,2.29), < 0.001 | 1.77 (1.34,2.34), < 0.001 |
Sensitivity analysis by excluding those with pre-diabetes at baseline. | ||||
Intermittent use vs. no use | 0.92 (0.73,1.16), 0.455 | 0.85 (0.67,1.08), 0.176 | 0.84 (0.66,1.07), 0.155 | 086 (0.67.1.10). 0.229 |
Persistent use vs. no use | 1.63 (1.22,2.18), 0.001 | 1.49 (1.11,1.99), 0.007 | 1.53 (1.13,2.07), 0.006 | 1.58 (1.16,2.17), 0.004 |